NCT02173795View on ClinicalTrials.gov

Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition

PHASE3CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

June 30, 2003

Conditions
Pulmonary Disease, Chronic ObstructiveAsthma
Interventions
DRUG

Berodual® Respimat®

DRUG

Berodual® MA HFA

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02173795 - Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition | Biotech Hunter | Biotech Hunter